John T. O’Malley

4.2k citations

50 papers · 2.4k indexed · 2 hit papers · h-index 23

Impact in

Dermatology top 0.5%
- Dermatology and Skin Diseases
- Cutaneous lymphoproliferative disorders research
Immunology top 2%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Psoriasis: Treatment and Pathogenesis
- Immunotherapy and Immune Responses

Papers in

Dermatology 30
- Dermatology and Skin Diseases 19
- Cutaneous lymphoproliferative disorders research 9
Immunology and Allergy 7

Co-authors: Rachael A. Clark Thomas S. Kupper Mark H. Kaplan James G. Krueger Gretta L. Stritesky Anubhav Mathur Jessica E. Teague Qing Yu
Journals: The Journal of Immunology (6 papers)Journal of the American Academy of Dermatology (5 papers)Journal of Investigative Dermatology (5 papers)Journal of Allergy and Clinical Immunology (3 papers)British Journal of Dermatology (3 papers)
Partner nations: United States France Germany

In The Last Decade

John T. O’Malley

50 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials 2023 · 119 citations

Peers

Countries citing papers authored by John T. O’Malley

Since Specialization

Citations

This map shows the geographic impact of John T. O’Malley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. O’Malley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. O’Malley more than expected).

Fields of papers citing papers by John T. O’Malley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. O’Malley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. O’Malley. The network helps show where John T. O’Malley may publish in the future.

Co-authors

The 25 scholars most cited alongside John T. O’Malley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John T. O’Malley Line = papers co-authored together John T. O’Malley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pathophysiology of Prurigo Nodularis: Neuroimmune Dysregulation and the Role of Type 2 Inflammation Journal of Investigative Dermatology ·Shawn G. Kwatra, Sonja Ständer, Gil Yosipovitch, Brian Kim, Noah A. Levit, John T. O’Malley	2024	7
2	Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis Journal of Allergy and Clinical Immunology ·Stephan Weidinger, Andrew Blauvelt, Kim Papp, Adam Reich, Chih‐Hung Lee, Margitta Worm, Charles Lynde, Yoko Kataoka, Peter Foley, Xiaodan Wei, Wanling Wong, 隆小田嶋, Christine Weber, Seoung Pyo Han, Sonya Davey, Fabrice Hurbin, 刘永英, Karl Yen, John T. O’Malley, Charlotte Bernigaud	2024	12
3	Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial British Journal of Dermatology ·Stephan Weidinger, Thomas Bieber, Michael J. Cork, Adam Reich, Rosamund Wilson, Sonia Quaratino, Marisa Stebegg, Chris Curtin, Y. B. Chen, John T. O’Malley, Павло Дячук	2023	61
4	42275 Dupilumab Improves Itch, Skin Pain, and Sleep in Adult Patients With Prurigo Nodularis (LIBERTY PN-PRIME and PRIME2) Journal of the American Academy of Dermatology ·Shawn G. Kwatra, Gil Yosipovitch, Sonja Ständer, Isabelle Guillemin, Jérôme Msihid, Lee Teng Soh, Noah A. Levit, Ashish Bansal, John T. O’Malley, G Schott, Bjorn Thomas	2023	1
5	42895 Validation of the skin pain numeric rating scale (NRS) in prurigo nodularis (PN) based on clinical studies of dupilumab in adults with PN Journal of the American Academy of Dermatology ·G Schott, Zibo maternai, Бовэнь Цзэн, Rhonda Webb, Sonja Ständer, Brian Kim, John T. O’Malley, Ashish Bansal, Jérôme Msihid	2023	1
6	227 Efficacy and safety of amlitelimab (an anti-OX40 ligand antibody) in patients with moderate-to-severe atopic dermatitis (AD): 24-week results from a Phase 2b trial (STREAM-AD) Journal of Investigative Dermatology ·Stephan Weidinger, Andrew Blauvelt, Kim Papp, Adam Reich, Chien‐Hung Lee, Margitta Worm, Charles Lynde, Yoko Kataoka, Peter Foley, C. Weber, Wai T. Wong, 刘永英, Yashwant Kumar, John T. O’Malley, Charlotte Bernigaud	2023	4
7	43531 Validation of the Dermatology Life Quality Index (DLQI) in prurigo nodularis (PN) based on clinical studies of dupilumab in adults with PN Journal of the American Academy of Dermatology ·G Schott, Zibo maternai, Бовэнь Цзэн, Alex C. Yen, Sonja Ständer, Brian Kim, John T. O’Malley, Ashish Bansal, Jérôme Msihid	2023	1
8	Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials Nature Medicine ·Gil Yosipovitch, Nicholas Mollanazar, Sonja Ständer, Shawn G. Kwatra, Brian Kim, Elizabeth Laws, Leda Mannent, Nikhil Amin, Bolanle Akinlade, Heribert Staudinger, Naimish Patel, George D. Yancopoulos, David M. Weinreich, Sheldon Wang, Genming Shi, Ashish Bansal, John T. O’Malley Hit paper breakdown →	2023	119
9	Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE) American Journal of Clinical Dermatology ·Andrew Blauvelt, Emma Guttman‐Yassky, Amy S. Paller, Eric L. Simpson, Michael J. Cork, Jamie Weisman, John Browning, Weily Soong, Xian Sun, Zhen Chen, Matthew P. Kosloski, Mohamed Kamal, Dimittri Delevry, Chien‐Chia Chuang, John T. O’Malley, Ashish Bansal	2022	62
10	Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides Clinical Cancer Research ·John T. O’Malley, Adèle de Masson, Elizabeth L. Lowry, Anita Giobbie‐Hurder, Nicole R. LeBoeuf, Cecilia Larocca, Ahmed Gehad, S. Taeshawongsatein, Jessica E. Teague, David C. Fisher, Thomas S. Kupper, Phillip M. Devlin, Rachael A. Clark	2019	17
11	High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides Science Translational Medicine ·Adèle de Masson, John T. O’Malley, Christopher P. Elco, Eri Hayakawa, Sherrie J. Divito, Elizabeth L. Lowry, Marianne Tawa, David C. Fisher, Phillip M. Devlin, Jessica E. Teague, Nicole R. LeBoeuf, Ilan R. Kirsch, Harlan Robins, Rachael A. Clark, Thomas S. Kupper	2018	81
12	Staged development of long-lived T-cell receptor alpha beta T(H)17 resident memory T-cell population to Candida albicans after skin infection Journal of Allergy and Clinical Immunology ·Chang Ook Park, Xiujun Fu, Xiaodong Jiang, Youdong Pan, Jessica E. Teague, Nicholas Collins, Tian Tian, John T. O’Malley, Ryan Emerson, Ji Hye Kim, Yookyung Jung, Rei Watanabe, Robert C. Fuhlbrigge, Francis R. Carbone, Thomas Gebhardt, Rachael A. Clark, Charles P. Lin, Thomas S. Kupper	2018	5
13	314 Preferential expression of PD-1 on malignant T cells of CTCL may underlie disease worsening in patients undergoing anti-PD1 therapy Journal of Investigative Dermatology ·John T. O’Malley, Ahmed Gehad, Elizabeth L. Lowry, Jessica E. Teague, Nicole R. LeBoeuf, Thomas S. Kupper, Rachael A. Clark	2017	2
14	Staged development of long-lived T-cell receptor αβ TH17 resident memory T-cell population to Candida albicans after skin infection Journal of Allergy and Clinical Immunology ·Chang Ook Park, Xiujun Fu, Xiaodong Jiang, Youdong Pan, Jessica E. Teague, Nicholas Collins, Tian Tian, John T. O’Malley, Ryan Emerson, Ji Hye Kim, Yookyung Jung, Rei Watanabe, Robert C. Fuhlbrigge, Francis R. Carbone, Thomas Gebhardt, Rachael A. Clark, Charles P. Lin, Thomas S. Kupper	2017	100
15	Clinically resolved psoriatic lesions contain psoriasis-specific IL-17–producing αβ T cell clones Journal of Clinical Investigation ·Tiago R. Matos, John T. O’Malley, Elizabeth L. Lowry, David Hamm, Ilan R. Kirsch, Harlan Robins, Thomas S. Kupper, James G. Krueger, Rachael A. Clark	2017	207
16	STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides Clinical Cancer Research ·Pablo Vieyra-Garcia, Tianling Wei, Yu Tianyi, Simon Fredholm, Regina Fink‐Puches, Lorenzo Cerroni, Niels Ødum, John T. O’Malley, Robert Gniadecki, Peter Wolf	2016	36
17	Temporal Induction Pattern of STAT4 Target Genes Defines Potential for Th1 Lineage-Specific Programming The Journal of Immunology ·O. Le Borgne, Vivian T. Thieu, Anubhav Mathur, Qing Yu, Gretta L. Stritesky, Norman Yeh, John T. O’Malley, Narayanan B. Perumal, Mark H. Kaplan	2009	57
18	Stat4 Isoforms Differentially Regulate Inflammation and Demyelination in Experimental Allergic Encephalomyelitis The Journal of Immunology ·Caiqing Mo, Wanida Chearwae, John T. O’Malley, M. Hafizi, Saravanan Kanakasabai, Crystal C. Walline, Gretta L. Stritesky, O. Le Borgne, Narayanan B. Perumal, Mark H. Kaplan, John J. Bright	2008	34
19	STAT4 Isoforms Differentially Regulate Th1 Cytokine Production and the Severity of Inflammatory Bowel Disease The Journal of Immunology ·John T. O’Malley, Rajaraman Eri, Gretta L. Stritesky, Anubhav Mathur, Hua-Chen Chang, Harm HogenEsch, Mythily Srinivasan, Mark H. Kaplan	2008	29
20	Distinct roles of STAT4α and STAT4β in the pathogenesis of experimental allergic encephalomyelitis (B99) The Journal of Immunology ·Caiqing Mo, Wanida Chearwae, John T. O’Malley, Mark H. Kaplan, John J. Bright	2007	1

About John T. O’Malley

John T. O’Malley is a scholar working on Dermatology, Immunology and Allergy, Immunology, Pathology and Forensic Medicine and Oncology, having authored 50 papers that have together received 2.4k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (19 papers), T-cell and B-cell Immunology (11 papers), Cutaneous lymphoproliferative disorders research (9 papers), Asthma and respiratory diseases (9 papers), Psoriasis: Treatment and Pathogenesis (8 papers), Urticaria and Related Conditions (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). The work is most often cited by research in Dermatology (880 citations), Immunology (1.5k citations), Immunology and Allergy (257 citations), Pathology and Forensic Medicine (324 citations) and Oncology (475 citations). John T. O’Malley has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Rachael A. Clark, Thomas S. Kupper, Mark H. Kaplan, James G. Krueger, Gretta L. Stritesky, Anubhav Mathur, Jessica E. Teague, Qing Yu, Ahmed Gehad and David T. Levy. Their work appears in journals such as The Journal of Immunology, Journal of the American Academy of Dermatology, Journal of Investigative Dermatology, Journal of Allergy and Clinical Immunology and British Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact